Clinicians Beware, Ewing’s Sarcoma After 60 Is Elusive and Rare!

Ewing’s sarcoma is the second most common malignant bone tumor in children, with the worst outcomes seen in patients over the age of 20. However, the onset of the disease is much less common in people over the age of 30. This case represents the diagnostic dilemma posed by an otherwise “straight for...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Dean, Berg, Ethan, Ranjit, Eukesh, Bhandari, Priyanka, Sapra, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Family/General Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039360/
https://www.ncbi.nlm.nih.gov/pubmed/32140335
http://dx.doi.org/10.7759/cureus.6768
_version_ 1783500801128267776
author Davis, Dean
Berg, Ethan
Ranjit, Eukesh
Bhandari, Priyanka
Sapra, Amit
author_facet Davis, Dean
Berg, Ethan
Ranjit, Eukesh
Bhandari, Priyanka
Sapra, Amit
author_sort Davis, Dean
collection PubMed
description Ewing’s sarcoma is the second most common malignant bone tumor in children, with the worst outcomes seen in patients over the age of 20. However, the onset of the disease is much less common in people over the age of 30. This case represents the diagnostic dilemma posed by an otherwise “straight forward” case of back pain. Keeping the differential diagnosis sufficiently broad to include bone malignancies, so as not to delay diagnosis and treatment, provides the best chance at a positive outcome.
format Online
Article
Text
id pubmed-7039360
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-70393602020-03-05 Clinicians Beware, Ewing’s Sarcoma After 60 Is Elusive and Rare! Davis, Dean Berg, Ethan Ranjit, Eukesh Bhandari, Priyanka Sapra, Amit Cureus Family/General Practice Ewing’s sarcoma is the second most common malignant bone tumor in children, with the worst outcomes seen in patients over the age of 20. However, the onset of the disease is much less common in people over the age of 30. This case represents the diagnostic dilemma posed by an otherwise “straight forward” case of back pain. Keeping the differential diagnosis sufficiently broad to include bone malignancies, so as not to delay diagnosis and treatment, provides the best chance at a positive outcome. Cureus 2020-01-24 /pmc/articles/PMC7039360/ /pubmed/32140335 http://dx.doi.org/10.7759/cureus.6768 Text en Copyright © 2020, Davis et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Family/General Practice
Davis, Dean
Berg, Ethan
Ranjit, Eukesh
Bhandari, Priyanka
Sapra, Amit
Clinicians Beware, Ewing’s Sarcoma After 60 Is Elusive and Rare!
title Clinicians Beware, Ewing’s Sarcoma After 60 Is Elusive and Rare!
title_full Clinicians Beware, Ewing’s Sarcoma After 60 Is Elusive and Rare!
title_fullStr Clinicians Beware, Ewing’s Sarcoma After 60 Is Elusive and Rare!
title_full_unstemmed Clinicians Beware, Ewing’s Sarcoma After 60 Is Elusive and Rare!
title_short Clinicians Beware, Ewing’s Sarcoma After 60 Is Elusive and Rare!
title_sort clinicians beware, ewing’s sarcoma after 60 is elusive and rare!
topic Family/General Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039360/
https://www.ncbi.nlm.nih.gov/pubmed/32140335
http://dx.doi.org/10.7759/cureus.6768
work_keys_str_mv AT davisdean cliniciansbewareewingssarcomaafter60iselusiveandrare
AT bergethan cliniciansbewareewingssarcomaafter60iselusiveandrare
AT ranjiteukesh cliniciansbewareewingssarcomaafter60iselusiveandrare
AT bhandaripriyanka cliniciansbewareewingssarcomaafter60iselusiveandrare
AT sapraamit cliniciansbewareewingssarcomaafter60iselusiveandrare

Ejemplares similares